“Future Generics” book series: New Volumes III and IV


Volumes III and IV of the popular "Future Generics" book series are being edited by Dr. Abram Becker and are now available for purchase.

Active ingredients, key intermediates, synthetic routes, market information, generic entry and market authorizations are presented for 275 active pharmaceutical ingredients.
The books are powerful resources for market evaluation presenting hundreds of business opportunities.

The selling price is € 1700 per volume.

Volume III (Abatacept to Kinetin, 132 monographs) contains 723 pages.
Volume IV (Lactitol to Zotarolimus, 143 monographs) contains 715 pages.
Both volumes index Product Name, Product Nomenclature, Therapeutic Categories, Originator and Developer, CAS Number, General Formula and Intermediate Nomenclature.

For further details, including a list of products included in the books, please contact
Dr Abram Becker, Becker & Associates
e-mail : beckerab@beckerdata.com
Office: +33 1 48 87 75 44 Fax: +33 1 48 87 12 05
  4/8  


  B&A to exhibit at CPhI 2010 Paris 5-7 October 2010
  High potency drugs in clinical trials
  INTERMEDIATES Annual Volumes
  “Future Generics” book series: New Volumes III and IV
  High potency drugs study
Show the cart